Humex Allergie (Loratadine)

Humex Allergie is indicated for the symptomatic treatment of common allergic conditions. It is used to alleviate the discomfort caused by histamine release in the body.

• Seasonal allergic rhinitis (hay fever)
• Perennial allergic rhinitis
• Acute urticaria (hives)
• Allergic conjunctivitis associated with rhinitis
• Relief of itching, sneezing, and nasal congestion due to allergies

• Loratadine, the active component of Humex Allergie, acts as a selective peripheral H1‑receptor antagonist. By binding competitively to H1 receptors on mast cells and other tissues, it blocks the action of histamine, a key mediator of allergic inflammation. This inhibition reduces vasodilation, increased vascular permeability, and sensory nerve stimulation, thereby diminishing typical allergic symptoms without crossing the blood‑brain barrier significantly.

Adverse reactions to Humex Allergie are generally mild, but serious events can occur in rare cases.

Common

• Headache
• Dry mouth
• Fatigue or mild drowsiness
• Nausea
• Dizziness

Serious

• Severe skin rash or Stevens‑Johnson syndrome
• Anaphylactic reaction
• Hepatotoxicity (rare)
• Cardiac arrhythmia (very rare)

Before using Humex Allergie, consider the following safety points.

• Consult a healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.
• Use caution in patients with severe liver impairment.
• Avoid use in individuals with known hypersensitivity to loratadine or any excipients.
• Do not combine with other antihistamines without medical advice.
• Monitor for signs of rash or swelling that could indicate an allergic reaction.
• Keep out of reach of children; accidental ingestion may require medical attention.

Humex Allergie may interact with other substances that affect its metabolism or increase sedative effects.

Avoid

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) that can raise loratadine levels.
• Other sedating antihistamines or central nervous system depressants.

Use with caution

• Alcohol, which may enhance drowsiness.
• Antifungal agents that moderately inhibit CYP3A4.
• Certain antidepressants (e.g., fluvoxamine) that can alter loratadine clearance.
• Herbal supplements such as St. John’s wort, which may affect metabolism.
• Medications that prolong QT interval, though risk is low.